About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
- WOMEN
- 2026 Readers' Choice Awards
Classifieds
Weather
Obituaries
2026 Readers' Choice Winners

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

549.97 -21.41 (-3.75%)

Delayed Quote Updated: 11:52 AM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Acceleron Stock Heats Up On $11 Billion Takeover Rumor; So, Who's The Buyer? ↗

September 27, 2021

A biotech working in lung and blood diseases, as well as cancer, could be acquired.

Via Investor's Business Daily

United Therapeutics-MannKind's Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients ↗

September 07, 2021

United Therapeutics Corporation (NASDAQ: UTHR) has presented new clinical data from the BREEZE study evaluating Tyvaso DPI (treprostinil) in patients with pulmonary...

Via Benzinga

Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments

August 05, 2021

Via FinancialNewsMedia

Why United Therapeutics Blasted 14% Higher Today ↗

August 04, 2021

Every one of the company's products booked a revenue gain in Q2.

Via The Motley Fool

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 09, 2021

During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set...

Via Benzinga

88 Biggest Movers From Yesterday ↗

August 05, 2021

Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...

Via Benzinga

United Therapeutics Corporation (UTHR) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

UTHR earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

United Therapeutics: Q2 Earnings Insights ↗

August 04, 2021

Shares of United Therapeutics (NASDAQ:UTHR) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share increased 11.14% over the past...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mostly lower Ahead Of General Motors Earnings ↗

August 04, 2021

Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade after the Dow Jones surged around 280 points in the previous session. Investors are awaiting...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

Earnings Scheduled For August 4, 2021 ↗

August 04, 2021

Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 ↗

July 14, 2021

Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:

Via Benzinga

MannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension ↗

June 16, 2021

MannKind Corporation (NASDAQ: MNKD) and United Therapeutics Corporation (NASDAQ: UTHR) have announced that the FDA has accepted for review the marketing...

Via Benzinga

Price Over Earnings Overview: United Therapeutics ↗

May 06, 2021

Looking into the current session, United Therapeutics Inc. (NASDAQ:UTHR) is trading at $193.48, after a 2.35% decrease. Over the past month, the stock fell by 3.61...

Via Benzinga

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

May 06, 2021

Rosenblatt lifted the price target on Qorvo Inc (NASDAQ: QRVO) from $175 to $200. Qorvo shares rose 0.8% to $184.01 in pre-market trading. Needham boosted HubSpot Inc (NASDAQ:...

Via Benzinga

United Therapeutics Corp (UTHR) Q1 2021 Earnings Call Transcript ↗

May 05, 2021

UTHR earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

United Therapeutics: Q1 Earnings Insights ↗

May 05, 2021

Shares of United Therapeutics (NASDAQ:UTHR) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share were down 3.32% year over year to $3....

Via Benzinga

A Peek Into The Markets: US Stock Futures Gain; General Motors Earnings In Focus ↗

May 05, 2021

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq dipped more than 260 points in the previous session. Investors are awaiting earnings...

Via Benzinga

Stocks That Hit 52-Week Highs On Wednesday ↗

April 21, 2021

Before 10 a.m. ET on Wednesday, 140 companies hit new 52-week highs. Noteworthy Highlights: The largest company by market cap to set a new 52-week high was...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

April 20, 2021

This morning 147 companies reached new 52-week highs. Noteworthy Mentions: UnitedHealth Group (NYSE:UNH) was the company with the largest market cap to set a new 52...

Via Benzinga

The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗

April 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

United Therapeutics Corporation - Common Stock (NQ:UTHR)

All News about United Therapeutics Corporation - Common Stock

Sections

Services

Contact Information

Follow Us